APA (7th ed.) Citation

Hein, S., Furkel, J., Knoll, M., Siepen, F. a. d., Schönland, S., Hegenbart, U., . . . Konstandin, M. (2021). Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis. Clinical research in cardiology, 110(4), . https://doi.org/10.1007/s00392-020-01801-y

Chicago Style (17th ed.) Citation

Hein, Selina, Jennifer Furkel, Maximilian Knoll, Fabian aus dem Siepen, Stefan Schönland, Ute Hegenbart, Hugo Katus, Arnt Kristen, and Mathias Konstandin. "Impaired in Vitro Growth Response of Plasma-treated Cardiomyocytes Predicts Poor Outcome in Patients with Transthyretin Amyloidosis." Clinical Research in Cardiology 110, no. 4 (2021). https://doi.org/10.1007/s00392-020-01801-y.

MLA (9th ed.) Citation

Hein, Selina, et al. "Impaired in Vitro Growth Response of Plasma-treated Cardiomyocytes Predicts Poor Outcome in Patients with Transthyretin Amyloidosis." Clinical Research in Cardiology, vol. 110, no. 4, 2021, https://doi.org/10.1007/s00392-020-01801-y.